# Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

> clinical trial · VERIFIED · 2026-08-04

Status: RECRUITING · Sponsor: Xuanwu Hospital, Beijing · Condition: Refractory Status Epilepticus

- Company: Xuanwu Hospital, Beijing
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT06344338

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.